The effect of BCG vaccination on infection and antibody levels against SARS-CoV-2—The results of ProBCG: a multicenter randomized clinical trial in Brazil

International Journal of Infectious Diseases - Tập 130 - Trang 8-16 - 2023
Ana Paula Santos1,2, Guilherme Loureiro Werneck3, Ana Paula Razal Dalvi3, Carla Conceição dos Santos1, Paulo Fernando Guimarães Morando Marzocchi Tierno4, Hanna Silva Condelo5, Bruna Macedo2, Janaina Aparecida de Medeiros Leung1,2, Jeane de Souza Nogueira5, Ludmila Malvão1, Rafael Galliez1, Roberta Aguiar1, Roberto Stefan6, Sabrina Modena Knackfuss1, Elisangela Costa da Silva7, Terezinha Marta Pereira Pinto Castineiras1, Roberto de Andrade Medronho1, José Roberto Lapa e Silva1, Rogério Lopes Rufino Alves2, Luís Cristóvão de Moraes Sobrino Porto5
1Thorax Diseases Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
2Pedro Ernesto University Hospital, State University of Rio de Janeiro, Rio de Janeiro, Brazil
3Collective Health Studies Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
4Barueri County Hospital, São Paulo Association for Medicine Development, São Paulo, Brazil
5Histocompatibility Laboratory, State University of Rio de Janeiro, Rio de Janeiro, Brazil
6Medical Sciences School, State University of Rio de Janeiro, Rio de Janeiro, Brazil
7Molecular Micobacteriology Laboratory, Medical School and Hospital Complex HUCFF-IDT - Federal University of Rio de Janeiro, Rio de Janeiro, Brazil

Tài liệu tham khảo

World Health Organization. Director General's Opening Remarks at the Media Briefing on COVID-19, https://covid19.who.int/2020 [accessed 09 September 2022]. Malik, 2020, BCG vaccine: a hope to control COVID-19 pandemic amid crisis, Hum Vaccin Immunother, 16, 2954, 10.1080/21645515.2020.1818522 Miller A, Raendelar MJ, Fasciglione K, Roumenova V, Li Y, Otazu GH. Correlation between universal BCG vaccination policy and reduced morbidity and mortality for COVID-19: an epidemiological study. medRxiv. 28 March 2020. https://www.medrxiv.org/content/10.1101/2020.03.24.20042937v1 [accessed 10 August 2022]. Covián, 2019, BCG-induced cross-protection and development of trained immunity: implication for vaccine design, Front Immunol, 10, 2806, 10.3389/fimmu.2019.02806 Khan, 2021, COVID-19 pandemic and vaccines update on challenges and resolutions, Front Cell Infect Microbiol, 11, 10.3389/fcimb.2021.690621 O'Neill, 2020, BCG-induced trained immunity: can it offer protection against COVID-19?, Nat Rev Immunol, 20, 335, 10.1038/s41577-020-0337-y Nankabirwa, 2015, Child survival and BCG vaccination: a community based prospective cohort study in Uganda, BMC Public Health, 15, 175, 10.1186/s12889-015-1497-8 Moorlag, 2019, Non-specific effects of BCG vaccine on viral infections, Clin Microbiol Infect, 25, 1473, 10.1016/j.cmi.2019.04.020 Adesanya, 2021, Bacillus Calmette-Guerin (BCG): the adroit vaccine, AIMS Microbiol, 7, 96, 10.3934/microbiol.2021007 Brasil. Inf Tecn Campanha Nac Vacinação Contra Covid, https://www.gov.br/saude/pt-br/coronavirus/notas-tecnicas/; 2021 [accessed 13 September 2022]. 2014 2020 Cox, 1972, Regression models and Life-Tables, J R Stat Soc, 34, 187 Giamarellos-Bourboulis, 2020, Activate: randomized clinical trial of BCG vaccination against infection in the elderly, Cell, 183, 315, 10.1016/j.cell.2020.08.051 Tsilika, 2022, ACTIVATE-2: a double-blind randomized trial of BCG vaccination against COVID19 in individuals at risk, Front Immunol, 13 Channappanavar, 2014, T cell-mediated immune response to respiratory coronaviruses, Immunol Res, 59, 118, 10.1007/s12026-014-8534-z Eggenhuizen, 2021, BCG vaccine derived peptides induce SARS-CoV-2 T cell cross-reactivity, Front Immunol, 12, 10.3389/fimmu.2021.692729 Nuovo, 2020, Strong homology between SARS-CoV-2 envelope protein and a Mycobacterium sp. antigen allows rapid diagnosis of Mycobacterial infections and may provide specific anti-SARS-CoV-2 immunity via the BCG vaccine, Ann Diagn Pathol, 48, 10.1016/j.anndiagpath.2020.151600 Dos Anjos, 2022, Efficacy and safety of BCG revaccination with M. bovis BCG Moscow to prevent COVID-19 infection in health care workers: a randomized Phase II clinical trial, Front Immunol, 13, 10.3389/fimmu.2022.841868 Rakshit S, Adiga V, Ahmed A, Parthiban C, Kumar N, et al. BCG revaccination qualitatively and quantitatively enhances SARS-CoV-2 spike-specific neutralizing antibody and T cell responses induced by the COVISHIELD vaccine in SARS-CoV-2 seronegative young Indian adults. Research Square. 02 March 2022. https://www.researchsquare.com/article/rs-1395683/v1. [accessed 28 August 2022]. Ramos-Martinez, 2021, Effect of BCG revaccination on occupationally exposed medical personnel vaccinated against SARS-CoV-2, Cells, 10, 3179, 10.3390/cells10113179 Czajka, 2022, Vaccines (Basel), 10, 314, 10.3390/vaccines10020314 Upton, 2022, Safety and efficacy of BCG re-vaccination in relation to COVID-19 morbidity in healthcare workers: a double-blind, randomised, controlled, phase 3 trial, EClinicalMedicine, 48, 10.1016/j.eclinm.2022.101414 Ritz, 2012, The influence of bacille calmette-guerin vaccine strain on the immune response against tuberculosis: a randomized trial, Am J Respir Crit Care Med, 185, 213, 10.1164/rccm.201104-0714OC Gupta, 2021, Positive QuantiFERON test and the severity of COVID-19 disease: a prospective study, Indian J Tuberc, 68, 474, 10.1016/j.ijtb.2020.12.013 Ward, 2021, Indeterminate QuantiFERON gold plus results reveal deficient interferon gamma responses in severely ill COVID-19 patients, J Clin Microbiol, 59, 10.1128/JCM.00811-21 Ten Doesschate, 2022, Bacillus Calmette-Guérin vaccine to reduce healthcare worker absenteeism in COVID-19 pandemic, a randomized controlled trial, Clin Microbiol Infect, 28, 1278, 10.1016/j.cmi.2022.04.009 Dionato, 2022, BCG vaccine safety in COVID-19 convalescent adults: BATTLE a randomized controlled trial, Vaccine, 40, 4603, 10.1016/j.vaccine.2022.06.039 Villanueva, 2022, Revaccination with Bacille Calmette-Guérin (BCG) is associated with an increased risk of abscess and lymphadenopathy, npj Vaccines, 7, 6, 10.1038/s41541-021-00421-5